Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 362.5% ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perspective Therapeutics (CATX – Research ...

In this article, we are going to look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...

BioMarin Pharmaceutical Inc. has a one year low of $60.63 and a one year high of $94.85. The company has a 50-day simple moving average of $66.68 and a two-hundred day simple moving average of $67.87.

San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for life-threatening severe medical conditions, mainly for children. BMRN boasts a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...